Open Payments

CHILDRENS MERCY HOSPITAL

Type
Teaching hospital
Where
Kansas City, MO
Medicare CCN
263302
Received
$2,272,920 in 504 records, 2020 ($17,457 general, $2,255,463 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2020General payment25$17,457
2020Research payment479$2,255,463

By company

CompanyRecordsAmountYears
BioFire Diagnostics, LLC35$493,5502020
JAZZ PHARMACEUTICALS INC.6$321,2482020
VERTEX PHARMACEUTICALS INCORPORATED12$300,7942020
Merck Sharp & Dohme LLC70$288,3172020
Edwards Lifesciences Corporation22$184,9122020
Amgen Inc.21$98,8402020
Dexcom, Inc.12$82,7552020
Astellas Pharma Global Development5$81,4002020
Genentech, Inc.13$60,2622020
ABBVIE INC.12$40,8992020
Travere Therapeutics, Inc.38$25,8192020
Eli Lilly and Company6$25,6572020
Gilead Sciences, Inc.29$22,9382020
Boehringer Ingelheim Pharmaceuticals, Inc.2$20,7502020
PFIZER INC.20$18,9452020
United Therapeutics Corporation6$18,0732020
Mallinckrodt Hospital Products Inc.5$17,9582020
DiaSorin Molecular LLC1$17,7892020
Alexion Pharmaceuticals, Inc.36$17,5102020
GLOBAL BLOOD THERAPEUTICS, INC.9$17,0502020
Allergan, Inc.6$12,2182020
Aimmune Therapeutics, Inc.11$11,2012020
New York Blood Center, Inc.1$9,8272020
Novo Nordisk AS9$9,6732020
IBSA Pharma Inc.1$9,1002020
E.R. Squibb & Sons, L.L.C.4$8,8382020
Astellas US Technologies26$8,2002020
SANOFI PASTEUR INC.2$7,7052020
Boehringer Ingelheim Pharma GmbH & Co.KG3$5,8652020
SANOFI US SERVICES INC.6$4,5572020
Novartis Pharmaceuticals Corporation3$3,9802020
LEICA MICROSYSTEMS INC.18$3,0042020
Celgene Corporation1$2,8062020
Abbott Laboratories4$2,4732020
Streck LLC1$2,4002020
Takeda Pharmaceuticals U.S.A., Inc.2$2,2312020
Incyte Corporation9$2,1142020
Boehringer Ingelheim Italia S.p.A.20$2,0082020
Cumberland Pharmaceuticals, Inc.1$1,3002020
AMAG Pharmaceuticals, Inc.2$1,3002020
AstraZeneca UK Limited2$1,0462020
Daiichi Sankyo Inc.1$1,0002020
Siemens Medical Solutions USA, Inc.2$9722020
BioMarin Pharmaceutical Inc.2$8602020
Draeger Medical Systems, Inc1$6002020
Covidien LP1$6002020
VIVUS LLC2$5382020
Stryker Corporation1$5252020
ZOLL Medical Corporation1$5002020
Zimmer Biomet Holdings, Inc.1$02020

By nature of payment

NatureRecordsAmount
Research payment479$2,255,463
Compensation for services other than consulting, including serving as faculty or as a speaker at a v2$12,227
Gift20$3,530
Space rental or facility fees (teaching hospital only)3$1,700

Records

DateCompanyAmountNatureFormProductStudyYear
2020-12-31Siemens Medical Solutions USA, Inc.$859Research paymentCash or cash equivalentTCH2019MRIPR785Mazur2020
2020-12-31Stryker Corporation$525GiftCash or cash equivalentNONE Device, NONE2020
2020-12-31AstraZeneca UK Limited$46Research paymentIn-kind items and servicesBYDUREON Drug, Cardiovascular and MetabolismA Phase 3 Double Blind Placebo Controlled Randomized Multi Center Study To Assess the Safety and Efficacy of Exenatide O2020
2020-12-31Aimmune Therapeutics, Inc.$18Research paymentCash or cash equivalentPALFORZIA Biological, ALLERGYA MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-12-31Zimmer Biomet Holdings, Inc.$0GiftIn-kind items and services Device, Zimmer Biomet Instruments and Implants2020
2020-12-29Merck Sharp & Dohme LLC$5,405Research paymentCash or cash equivalentV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-12-28Aimmune Therapeutics, Inc.$200Research paymentCash or cash equivalentPALFORZIA Biological, ALLERGYA MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-12-24Amgen Inc.$6,050Research paymentCash or cash equivalentKyprolis Drug, OncologyKyprolis (CFZ) Ph1/2 Pediatric ALL2020
2020-12-24Amgen Inc.$692Research paymentCash or cash equivalentParsabiv Drug, NephrologyPediatric Multi-Dose2020
2020-12-23Edwards Lifesciences Corporation$8,745Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesALTERRA Early Feasibility (2016-04)2020
2020-12-23Edwards Lifesciences Corporation$4,569Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesCOMPASSION S3 2015-012020
2020-12-23Gilead Sciences, Inc.$633Research paymentCash or cash equivalentSovaldi Drug, HCVA Long Term Follow-up Registry for Pediatric Subjects Who Received Treatment in Gilead-Sponsored Chronic Hepatitis C Inf2020
2020-12-22JAZZ PHARMACEUTICALS INC.$180,000Research paymentCash or cash equivalentDEFITELIO Drug, HEMATOLOGY/ONCOLOGYA PHASE 3, RANDOMIZED, ADAPTIVE STUDY COMPARING THE EFFICACY AND SAFETY OF DEFIBROTIDE VS BEST SUPPORTIVE CARE IN THE PR2020
2020-12-22Novo Nordisk AS$200Research paymentCash or cash equivalentSogroya Biological, Growth HormoneNN8640-42632020
2020-12-21GLOBAL BLOOD THERAPEUTICS, INC.$1,049Research paymentCash or cash equivalentOXBRYTA Drug, SICKLE CELL DISEASEGBT_GBT440-038_3702_012020
2020-12-18SANOFI US SERVICES INC.$296Research paymentCash or cash equivalentDUPIXENT Biological, ImmunologyObservational Evaluation of Atopic Dermatitis in Pediatric Patients (PEDISTAD)2020
2020-12-17ABBVIE INC.$466Research paymentCash or cash equivalentLUPRON DEPOT Drug, ENDOCRINOLOGYM16-9042020
2020-12-17Boehringer Ingelheim Italia S.p.A.$212Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYPediatric ILD program2020
2020-12-15Travere Therapeutics, Inc.$1,150Research paymentCash or cash equivalent021FSGS160102020
2020-12-15Travere Therapeutics, Inc.$920Research paymentCash or cash equivalent021FSGS160102020
2020-12-14BioFire Diagnostics, LLC$195Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI STA Pivotal Study2020
2020-12-09BioFire Diagnostics, LLC$242Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsSpotFire RST Study2020
2020-12-08GLOBAL BLOOD THERAPEUTICS, INC.$1,049Research paymentCash or cash equivalentOXBRYTA Drug, SICKLE CELL DISEASEGBT_GBT440-038_3702_012020
2020-12-08Incyte Corporation$21Research paymentCash or cash equivalentA Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub2020
2020-12-08Incyte Corporation$12Research paymentCash or cash equivalentA Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub2020
2020-12-08Incyte Corporation$12Research paymentCash or cash equivalentA Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub2020
2020-12-08Incyte Corporation$12Research paymentCash or cash equivalentA Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub2020
2020-12-07GLOBAL BLOOD THERAPEUTICS, INC.$1,190Research paymentCash or cash equivalentOXBRYTA Drug, SICKLE CELL DISEASEGBT_GBT_PEDIATRIC_440-007_2926_012020
2020-12-03Edwards Lifesciences Corporation$53,763Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesALTERRA Early Feasibility (2016-04)2020
2020-12-03Genentech, Inc.$7,705Research paymentCash or cash equivalentMircera Biological, HematologyCONFIRMATORY STUDY2020
2020-12-03BioFire Diagnostics, LLC$1,248Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsSpotFire RST Study2020
2020-12-02IBSA Pharma Inc.$9,100Research paymentCash or cash equivalentTirosint Drug, EndocrinologyUse of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients2020
2020-12-02Gilead Sciences, Inc.$718Research paymentCash or cash equivalentVemlidy Drug, HBVA Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Ala2020
2020-12-01Travere Therapeutics, Inc.$293Research paymentCash or cash equivalent021FSGS160102020
2020-12-01Boehringer Ingelheim Italia S.p.A.$122Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYPediatric ILD program2020
2020-12-01Travere Therapeutics, Inc.$26Research paymentCash or cash equivalentDUET2020
2020-11-27Edwards Lifesciences Corporation$20,293Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesCOMPASSION S3 2015-012020
2020-11-25Novo Nordisk AS$1,950Research paymentCash or cash equivalentSogroya Biological, Growth HormoneNN8640-42632020
2020-11-25Novo Nordisk AS$797Research paymentCash or cash equivalentSogroya Biological, Growth HormoneNN8640-42632020
2020-11-25Merck Sharp & Dohme LLC$30Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-11-24Mallinckrodt Hospital Products Inc.$1,000Research paymentCash or cash equivalentINOMAX Drug, CRITICAL CAREREGISTRY EVALUATING PREMATURE AND TERM-NEAR-TERM NEONATES WITH PULMONARY HYPERTENSION RECEIVING INHALED NITRIC OXIDE2020
2020-11-20GLOBAL BLOOD THERAPEUTICS, INC.$3,665Research paymentCash or cash equivalentOXBRYTA Drug, SICKLE CELL DISEASEGBT_GBT440-038_3702_012020
2020-11-19Dexcom, Inc.$14,562Research paymentCash or cash equivalentDEXCOM G6 CGM SYSTEM Device, ENDOCRINOLOGYPOST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH)2020
2020-11-19Travere Therapeutics, Inc.$400Research paymentCash or cash equivalent021FSGS160102020
2020-11-19Merck Sharp & Dohme LLC$200Research paymentCash or cash equivalentV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-11-18Gilead Sciences, Inc.$2,312Research paymentCash or cash equivalentVemlidy Drug, HBVA Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Ala2020
2020-11-18Travere Therapeutics, Inc.$1,069Research paymentCash or cash equivalent021FSGS160102020
2020-11-18Travere Therapeutics, Inc.$960Research paymentCash or cash equivalent021FSGS160102020
2020-11-18Travere Therapeutics, Inc.$960Research paymentCash or cash equivalent021FSGS160102020
2020-11-18Travere Therapeutics, Inc.$663Research paymentCash or cash equivalent021FSGS160102020
2020-11-18Gilead Sciences, Inc.$633Research paymentCash or cash equivalentSovaldi Drug, HCVA Long Term Follow-up Registry for Pediatric Subjects Who Received Treatment in Gilead-Sponsored Chronic Hepatitis C Inf2020
2020-11-17Merck Sharp & Dohme LLC$3,100Research paymentCash or cash equivalentV114 Biological, VACCINEA Phase 3, Randomized, Double-blind, Active Comparator-controlled, Multicenter Clinical Study to Evaluate the Safety, To2020
2020-11-16Gilead Sciences, Inc.$60Research paymentCash or cash equivalentSovaldi Drug, HCVA Long Term Follow-up Registry for Pediatric Subjects Who Received Treatment in Gilead-Sponsored Chronic Hepatitis C Inf2020
2020-11-11Gilead Sciences, Inc.$1,000Research paymentCash or cash equivalentVemlidy Drug, HBVA Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Ala2020
2020-11-11Merck Sharp & Dohme LLC$93Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-11-11Merck Sharp & Dohme LLC$30Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-11-11Merck Sharp & Dohme LLC$17Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-11-11Merck Sharp & Dohme LLC$15Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-11-10SANOFI PASTEUR INC.$1,955Research paymentCash or cash equivalentSTA00011 Stamaril Yellow Fever2020
2020-11-10Alexion Pharmaceuticals, Inc.$1,500Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-11-06Novo Nordisk AS$46Research paymentCash or cash equivalentNN8640-42632020
2020-11-05Abbott Laboratories$655Research paymentIn-kind items and servicesFreeStyle Lite system Device, Diabetes CareREDCHiP: Reducing Emotional Distress for Childhood Hypoglycemia in Parents2020
2020-11-05Abbott Laboratories$518Research paymentIn-kind items and servicesFreeStyle Lite system Device, Diabetes CareREDCHiP: Reducing Emotional Distress for Childhood Hypoglycemia in Parents2020
2020-11-03Merck Sharp & Dohme LLC$203Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-11-02Travere Therapeutics, Inc.$418Research paymentCash or cash equivalent021FSGS160102020
2020-11-01Boehringer Ingelheim Italia S.p.A.$119Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYPediatric ILD program2020
2020-10-29GLOBAL BLOOD THERAPEUTICS, INC.$4,757Research paymentCash or cash equivalentOXBRYTA Drug, SICKLE CELL DISEASEGBT_GBT_PEDIATRIC_440-007_2926_012020
2020-10-29GLOBAL BLOOD THERAPEUTICS, INC.$1,341Research paymentCash or cash equivalentOXBRYTA Drug, SICKLE CELL DISEASEGBT_GBT_PEDIATRIC_440-007_2926_012020
2020-10-29PFIZER INC.$1,068Research paymentIn-kind items and servicesIBRANCE Drug, ONCOLOGYAN OPEN LABEL PHASE 12 CLINICAL STUDY OF PD0332991 IN COMBINATION WITH BACKBONE CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH 2020
2020-10-27Novo Nordisk AS$2,233Research paymentCash or cash equivalentNN8640-42632020
2020-10-27Travere Therapeutics, Inc.$95Research paymentCash or cash equivalentDUET2020
2020-10-27Boehringer Ingelheim Italia S.p.A.$3Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYPediatric ILD program2020
2020-10-26Alexion Pharmaceuticals, Inc.$863Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-10-26Alexion Pharmaceuticals, Inc.$863Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-10-26Alexion Pharmaceuticals, Inc.$863Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-10-26Alexion Pharmaceuticals, Inc.$863Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-10-26Alexion Pharmaceuticals, Inc.$863Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-10-26Alexion Pharmaceuticals, Inc.$863Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-10-26Alexion Pharmaceuticals, Inc.$235Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-10-26Alexion Pharmaceuticals, Inc.$235Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-10-26Alexion Pharmaceuticals, Inc.$235Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-10-26Alexion Pharmaceuticals, Inc.$235Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-10-26Alexion Pharmaceuticals, Inc.$235Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-10-26Alexion Pharmaceuticals, Inc.$233Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-10-23Amgen Inc.$14,259Research paymentCash or cash equivalentKyprolis Drug, Oncology4020 - CFZ Ph1 Pediatric ALL (CFZ 008)2020
2020-10-23Dexcom, Inc.$9,229Research paymentCash or cash equivalentDEXCOM G6 CGM SYSTEM Device, ENDOCRINOLOGYPOST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH)2020
2020-10-22Merck Sharp & Dohme LLC$1,000Research paymentCash or cash equivalentKEYTRUDA Biological, ONCOLOGYA Phase I,II Study of Pembrolizumab MK-3475 in Children with advanced melanoma or a PD-L1 positive advanced, relapsed or2020
2020-10-22Novo Nordisk AS$186Research paymentCash or cash equivalentNN8640-42632020
2020-10-21BioFire Diagnostics, LLC$10,547Research paymentCash or cash equivalentFilmArray System Device, Clinical DiagnosticsFilmArray GI STA Pivotal Study2020
2020-10-19Travere Therapeutics, Inc.$410Research paymentCash or cash equivalent021FSGS160102020
2020-10-19Travere Therapeutics, Inc.$410Research paymentCash or cash equivalent021FSGS160102020
2020-10-19Travere Therapeutics, Inc.$130Research paymentCash or cash equivalent021FSGS160102020
2020-10-19Travere Therapeutics, Inc.$118Research paymentCash or cash equivalent021FSGS160102020
2020-10-17PFIZER INC.$262Research paymentCash or cash equivalentPREVNAR 13 Biological, VACCINESA PHASE 2 RANDOMIZED OPENLABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE V2020
2020-10-16Travere Therapeutics, Inc.$2,218Research paymentCash or cash equivalentDUET2020
2020-10-13PFIZER INC.$3,296Research paymentIn-kind items and servicesIBRANCE Drug, ONCOLOGYAN OPEN LABEL PHASE 12 CLINICAL STUDY OF PD0332991 IN COMBINATION WITH BACKBONE CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH 2020
2020-10-13PFIZER INC.$1,068Research paymentIn-kind items and servicesIBRANCE Drug, ONCOLOGYAN OPEN LABEL PHASE 12 CLINICAL STUDY OF PD0332991 IN COMBINATION WITH BACKBONE CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH 2020
2020-10-13PFIZER INC.$345Research paymentIn-kind items and servicesIBRANCE Drug, ONCOLOGYAN OPEN LABEL PHASE 12 CLINICAL STUDY OF PD0332991 IN COMBINATION WITH BACKBONE CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH 2020
2020-10-13PFIZER INC.$281Research paymentIn-kind items and servicesIBRANCE Drug, ONCOLOGYAN OPEN LABEL PHASE 12 CLINICAL STUDY OF PD0332991 IN COMBINATION WITH BACKBONE CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH 2020
2020-10-13PFIZER INC.$99Research paymentIn-kind items and servicesIBRANCE Drug, ONCOLOGYAN OPEN LABEL PHASE 12 CLINICAL STUDY OF PD0332991 IN COMBINATION WITH BACKBONE CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH 2020
2020-10-13PFIZER INC.$66Research paymentIn-kind items and servicesIBRANCE Drug, ONCOLOGYAN OPEN LABEL PHASE 12 CLINICAL STUDY OF PD0332991 IN COMBINATION WITH BACKBONE CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH 2020
2020-10-08BioFire Diagnostics, LLC$3,403Research paymentCash or cash equivalentGastrointestinal Panel Kit (RFIT-ASY-0116) Device, Clinical DiagnosticsEtiology and prevalence of acute gastroenteritis (AGE) in US children2020
2020-10-01BioFire Diagnostics, LLC$40,500Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI STA Pivotal Study2020
2020-10-01PFIZER INC.$262Research paymentCash or cash equivalentPREVNAR 13 Biological, VACCINESA PHASE 2 RANDOMIZED OPENLABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE V2020
2020-10-01Boehringer Ingelheim Italia S.p.A.$120Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYPediatric ILD program2020
2020-09-29Novo Nordisk AS$797Research paymentCash or cash equivalentNN8640-42632020
2020-09-28ABBVIE INC.$3,791Research paymentCash or cash equivalentLUPRON DEPOT Drug, ENDOCRINOLOGYM16-9042020
2020-09-28PFIZER INC.$2,700Research paymentCash or cash equivalentA PHASE 3 RANDOMIZED MULTICENTER OPENLABEL CROSSOVER STUDY ASSESSING SUBJECT PERCEPTION OF TREATMENT BURDEN WITH USE OF 2020
2020-09-28PFIZER INC.$2,500Research paymentCash or cash equivalentA PHASE 3 RANDOMIZED MULTICENTER OPENLABEL CROSSOVER STUDY ASSESSING SUBJECT PERCEPTION OF TREATMENT BURDEN WITH USE OF 2020
2020-09-28Genentech, Inc.$59Research paymentCash or cash equivalentMircera Biological, HematologyCONFIRMATORY STUDY2020
2020-09-24Merck Sharp & Dohme LLC$4,258Research paymentCash or cash equivalentV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-09-24Amgen Inc.$308Research paymentIn-kind items and servicesParsabiv Drug, NephrologyPediatric Multi-Dose2020
2020-09-24LEICA MICROSYSTEMS INC.$48GiftCash or cash equivalentN/A Device, CANCER DIAGNOSTICS2020
2020-09-23Gilead Sciences, Inc.$969Research paymentCash or cash equivalentVemlidy Drug, HBVA Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Ala2020
2020-09-22JAZZ PHARMACEUTICALS INC.$127,029Research paymentIn-kind items and servicesVYXEOS Drug, HEMATOLOGY/ONCOLOGYA STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED A2020
2020-09-18Boehringer Ingelheim Italia S.p.A.$77Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYPediatric ILD program2020
2020-09-18Boehringer Ingelheim Italia S.p.A.$53Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYPediatric ILD program2020
2020-09-17Dexcom, Inc.$3,076Research paymentCash or cash equivalentDEXCOM G6 CGM SYSTEM Device, ENDOCRINOLOGYPOST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH)2020
2020-09-17Travere Therapeutics, Inc.$715Research paymentCash or cash equivalent(810) Chenodal Drug, HepatologyProtocol No: 018CTXX150012020
2020-09-16Travere Therapeutics, Inc.$1,168Research paymentCash or cash equivalent021FSGS160102020
2020-09-16Travere Therapeutics, Inc.$1,168Research paymentCash or cash equivalent021FSGS160102020
2020-09-16Travere Therapeutics, Inc.$948Research paymentCash or cash equivalent021FSGS160102020
2020-09-16Travere Therapeutics, Inc.$948Research paymentCash or cash equivalent021FSGS160102020
2020-09-16Travere Therapeutics, Inc.$805Research paymentCash or cash equivalent021FSGS160102020
2020-09-16Travere Therapeutics, Inc.$220Research paymentCash or cash equivalent021FSGS160102020
2020-09-15Merck Sharp & Dohme LLC$406Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-09-15Merck Sharp & Dohme LLC$30Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-09-11BioFire Diagnostics, LLC$4,689Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI STA Pivotal Study2020
2020-09-09Genentech, Inc.$8,321Research paymentCash or cash equivalentMircera Biological, HematologyCONFIRMATORY STUDY2020
2020-09-07GLOBAL BLOOD THERAPEUTICS, INC.$2,098Research paymentCash or cash equivalentOXBRYTA Drug, SICKLE CELL DISEASEGBT_GBT440-038_3702_012020
2020-09-02Gilead Sciences, Inc.$718Research paymentCash or cash equivalentVemlidy Drug, HBVA Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Ala2020
2020-09-02Gilead Sciences, Inc.$585Research paymentCash or cash equivalentSovaldi Drug, HCVA Long Term Follow-up Registry for Pediatric Subjects Who Received Treatment in Gilead-Sponsored Chronic Hepatitis C Inf2020
2020-09-02Merck Sharp & Dohme LLC$93Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-09-02Merck Sharp & Dohme LLC$74Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-09-02Merck Sharp & Dohme LLC$30Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-09-02Merck Sharp & Dohme LLC$17Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-09-02Merck Sharp & Dohme LLC$15Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-09-01Boehringer Ingelheim Italia S.p.A.$122Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYPediatric ILD program2020
2020-09-01Travere Therapeutics, Inc.$26Research paymentCash or cash equivalentDUET2020
2020-08-31Boehringer Ingelheim Pharma GmbH & Co.KG$2,033Research paymentIn-kind items and servicesTRADJENTA Drug, DIABETES52 wks Eff. & Saf. Ph III in Paediatrics2020
2020-08-31Boehringer Ingelheim Pharma GmbH & Co.KG$2,033Research paymentIn-kind items and servicesTRADJENTA Drug, DIABETES52 wks Eff. & Saf. Ph III in Paediatrics2020
2020-08-31Boehringer Ingelheim Pharma GmbH & Co.KG$1,799Research paymentIn-kind items and servicesTRADJENTA Drug, DIABETES52 wks Eff. & Saf. Ph III in Paediatrics2020
2020-08-27ABBVIE INC.$4,815Research paymentCash or cash equivalentLUPRON DEPOT Drug, ENDOCRINOLOGYM16-9042020
2020-08-26Boehringer Ingelheim Italia S.p.A.$125Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYPediatric ILD program2020
2020-08-25Novo Nordisk AS$2,741Research paymentCash or cash equivalentNN8640-42632020
2020-08-22Dexcom, Inc.$8,204Research paymentCash or cash equivalentDEXCOM G6 CGM SYSTEM Device, ENDOCRINOLOGYPOST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH)2020
2020-08-20Merck Sharp & Dohme LLC$11,166Research paymentCash or cash equivalentV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-08-19Gilead Sciences, Inc.$1,439Research paymentCash or cash equivalentSovaldi Drug, HCVA Long Term Follow-up Registry for Pediatric Subjects Who Received Treatment in Gilead-Sponsored Chronic Hepatitis C Inf2020
2020-08-17Travere Therapeutics, Inc.$1,329Research paymentCash or cash equivalent021FSGS160102020
2020-08-17Travere Therapeutics, Inc.$1,063Research paymentCash or cash equivalent021FSGS160102020
2020-08-11Aimmune Therapeutics, Inc.$290Research paymentCash or cash equivalentPALFORZIA Biological, ALLERGYA MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-08-11Aimmune Therapeutics, Inc.$290Research paymentCash or cash equivalentPALFORZIA Biological, ALLERGYA MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-08-11Aimmune Therapeutics, Inc.$290Research paymentCash or cash equivalentPALFORZIA Biological, ALLERGYA MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-08-11Aimmune Therapeutics, Inc.$287Research paymentCash or cash equivalentPALFORZIA Biological, ALLERGYA MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-08-10Amgen Inc.$0Research paymentIn-kind items and servicesAimovig Biological, NeurosciencePh3 Pediatric CM Study.2020
2020-08-06Edwards Lifesciences Corporation$6,173Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesALTERRA Early Feasibility (2016-04)2020
2020-08-06ABBVIE INC.$1,199Research paymentCash or cash equivalentCREON Drug, ENDOCRINOLOGYP12-7922020
2020-08-06VIVUS LLC$403Research paymentCash or cash equivalentPANCREAZE Drug, CYSTIC FIBROSISLong-term Study in US Cystic Fibrosis2020
2020-08-01Boehringer Ingelheim Italia S.p.A.$121Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYPediatric ILD program2020
2020-07-31Merck Sharp & Dohme LLC$18,696Research paymentIn-kind items and servicesNEXPLANON Drug, WOMENS HEALTHIntervention to Facilitate Contraception Provision by Pediatric Hospitalists A Feasibility Study2020
2020-07-31Merck Sharp & Dohme LLC$975Research paymentIn-kind items and servicesNUVARING Drug, WOMENS HEALTHIntervention to Facilitate Contraception Provision by Pediatric Hospitalists A Feasibility Study2020
2020-07-30Edwards Lifesciences Corporation$4,000Research paymentCash or cash equivalentCOMPASSION Study 2006-092020
2020-07-30Edwards Lifesciences Corporation$569Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesCOMPASSION S3 2015-012020
2020-07-30GLOBAL BLOOD THERAPEUTICS, INC.$330Research paymentCash or cash equivalentOXBRYTA Drug, SICKLE CELL DISEASEGBT_GBT_PEDIATRIC_440-007_2926_012020
2020-07-29ABBVIE INC.$1,556Research paymentCash or cash equivalentLUPRON DEPOT Drug, ENDOCRINOLOGYM16-9042020
2020-07-28BioFire Diagnostics, LLC$9,305Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI STA Pivotal Study2020
2020-07-28Alexion Pharmaceuticals, Inc.$863Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-07-28Novo Nordisk AS$720Research paymentCash or cash equivalentNN8640-42632020
2020-07-28Alexion Pharmaceuticals, Inc.$235Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-07-28Alexion Pharmaceuticals, Inc.$235Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-07-28Alexion Pharmaceuticals, Inc.$235Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-07-28Alexion Pharmaceuticals, Inc.$235Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-07-28Alexion Pharmaceuticals, Inc.$15Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)2020
2020-07-27Merck Sharp & Dohme LLC$372Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-07-23Merck Sharp & Dohme LLC$4,696Research paymentCash or cash equivalentV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-07-23AMAG Pharmaceuticals, Inc.$300Research paymentCash or cash equivalentFERAHEME Drug, PARENTERAL IRON REPLACEMENTA PHASE 3, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE SAFETY (COMPARED TO IRON SUCROSE), EFFICACY AND PHA2020
2020-07-22Merck Sharp & Dohme LLC$25,556Research paymentCash or cash equivalentPRIMAXIN Drug, INFECTIOUS DISEASEComparative In Vitro Activity of Imipenem-Relebactam against Pediatric Drug-Resistant Gram Negative Isolates from three 2020
2020-07-22Gilead Sciences, Inc.$1,142Research paymentCash or cash equivalentVemlidy Drug, HBVA Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Ala2020
2020-07-22Gilead Sciences, Inc.$1,000Research paymentCash or cash equivalentEpclusa Drug, HCVA Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir 2020
2020-07-22Gilead Sciences, Inc.$633Research paymentCash or cash equivalentSovaldi Drug, HCVA Long Term Follow-up Registry for Pediatric Subjects Who Received Treatment in Gilead-Sponsored Chronic Hepatitis C Inf2020
2020-07-22United Therapeutics Corporation$500Research paymentCash or cash equivalentREMODULIN Drug, PAHINTRAVENOUS REMODULIN (TREPROSTINIL) AS ADD-ON THERAPY FOR THE TREATMENT OF PERSISTENT PULMONARY HYPERTENSION OF THE NEW2020
2020-07-22Eli Lilly and Company$251Research paymentIn-kind items and servicesA PHASE 3, 12 MONTH, OPEN LABEL STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE PIONEER PEDS22020
2020-07-22Eli Lilly and Company$123Research paymentIn-kind items and servicesPEDIATRIC OPTIONS FOR MIGRAINE RELIEF A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF LASMIDITAN FOR ACUTE TREA2020
2020-07-21SANOFI PASTEUR INC.$5,750Research paymentCash or cash equivalentSTA00011 Stamaril Yellow Fever2020
2020-07-20Amgen Inc.$1,680Research paymentIn-kind items and servicesParsabiv Drug, NephrologyAMG 416 Pediatric2020
2020-07-20Travere Therapeutics, Inc.$1,498Research paymentCash or cash equivalentDUET2020
2020-07-20Travere Therapeutics, Inc.$250Research paymentCash or cash equivalentDUET2020
2020-07-20Travere Therapeutics, Inc.$95Research paymentCash or cash equivalentDUET2020
2020-07-16Genentech, Inc.$8,112Research paymentCash or cash equivalentPegasys Biological, Virology & Specialty CarePEG LAMIVUDINE ENTECAVIR TX IN CHILDREN WITH CHRONIC HBV2020
2020-07-16Dexcom, Inc.$1,640Research paymentCash or cash equivalentDEXCOM G6 CGM SYSTEM Device, ENDOCRINOLOGYPOST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH)2020
2020-07-16Merck Sharp & Dohme LLC$187Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-07-16Merck Sharp & Dohme LLC$60Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-07-16Merck Sharp & Dohme LLC$49Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-07-16Merck Sharp & Dohme LLC$35Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-07-16Merck Sharp & Dohme LLC$30Research paymentIn-kind items and servicesV114 Biological, VACCINEA Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerabilit2020
2020-07-15Gilead Sciences, Inc.$1,150Research paymentCash or cash equivalentEpclusa Drug, HCVA Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir 2020
2020-07-09Amgen Inc.$46Research paymentIn-kind items and servicesAimovig Biological, NeurosciencePhase P3 Pediatric Study (EM).2020
2020-07-07Boehringer Ingelheim Italia S.p.A.$69Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYPediatric ILD program2020
2020-07-01BioFire Diagnostics, LLC$40,500Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI STA Pivotal Study2020
2020-07-01Aimmune Therapeutics, Inc.$3,786Research paymentCash or cash equivalentPALFORZIA Biological, ALLERGYA MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020

The latest 200 records of 504.

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Jackson CountyKansas City city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Kansas City, MO, county Jackson County, MO, state Missouri; placed by its city name.

MeasurePlace (city or town)
Kansas City, MO
County
Jackson County, MO
State
Missouri
Population B01003510,612719,9766,191,814
Population, 2020 census P1508,090717,2046,154,913
Median age B0100235.837.039.0
Under 18 B0100122.5%23.3%22.3%
65 and over B0100114.3%15.9%17.9%
Households B11001221,979306,7982,508,227
Foreign born B050028.6%6.6%4.5%
Median household income B19013$69,166$68,577$70,702
Median family income B19113$92,934$90,585$91,360
Per capita income B19301$41,393$39,559$39,695
Poverty rate B1700114.6%14.1%12.6%
Unemployment rate B230254.4%4.7%4.0%
Civilian labor force B23025279,828381,4333,120,639
Mean commute (minutes) B0801321.723.423.5
Bachelor's degree or higher B1500338.4%34.0%32.4%
Housing units B25001245,346336,2882,825,287
Owner-occupied B2500355.4%59.1%68.1%
Renters B2500344.6%40.9%31.9%
Median home value B25077$242,900$230,500$230,300
Median gross rent B25064$1,238$1,197$1,033
White, not Hispanic B0300254.0%59.3%76.3%
Black B0300225.2%22.0%10.9%
Hispanic or Latino B0300212.5%11.4%5.2%
Asian B030022.8%1.8%2.1%
American Indian and Alaska Native B030020.1%0.1%0.2%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Kansas City, MO.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.